| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article; Review
- Language: English
- [Br J Pharmacol] 2024 May; Vol. 181 (10), pp. 1500-1508. <i>Date of Electronic Publication: </i>2023 May 11.
- MeSH Terms: Receptors, G-Protein-Coupled* / metabolism ; Signal Transduction* ; Arrestin / metabolism ; Macrophages / metabolism ; Phosphorylation ; Humans
- References: Al Mahmud, Z., Jenkins, L., Ulven, T., Labéguère, F., Gosmini, R., De Vos, S., Hudson, B. D., Tikhonova, I. G., & Milligan, G. (2017). Three classes of ligands each bind to distinct sites on the orphan G protein‐coupled receptor GPR84. Scientific Reports, 7(1), 17953. https://doi.org/10.1038/s41598-017-18159-3. ; Alexander, S. P. H., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Southan, C., Davies, J. A., Abbracchio, M. P., Alexander, W., Al‐Hosaini, K., Bäck, M., Barnes, N. M., Bathgate, R., … Ye, R. D. (2021). THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors. British Journal of Pharmacology, 178, S27–S156. https://doi.org/10.1111/bph.15538. ; Burns, R. N., Singh, M., Senatorov, I. S., & Moniri, N. H. (2014). Mechanisms of homologous and heterologous phosphorylation of FFA receptor 4 (GPR120): GRK6 and PKC mediate phosphorylation of Thr347, Ser350, and Ser357 in the C‐terminal tail. Biochemical Pharmacology, 87, 650–659. https://doi.org/10.1016/j.bcp.2013.12.016. ; Butcher, A. J., Bradley, S. J., Prihandoko, R., Brooke, S. M., Mogg, A., Bourgognon, J. M., Macedo‐Hatch, T., Edwards, J. M., Bottrill, A. R., Challiss, R. A., Broad, L. M., Felder, C. C., & Tobin, A. B. (2016). An antibody biosensor establishes the activation of the M1 muscarinic acetylcholine receptor during learning and memory. The Journal of Biological Chemistry, 291, 8862–8875. https://doi.org/10.1074/jbc.M115.681726. ; Butcher, A. J., Prihandoko, R., Kong, K. C., McWilliams, P., Edwards, J. M., Bottrill, A., Mistry, S., & Tobin, A. B. (2010). Differential G‐protein‐coupled receptor phosphorylation provides evidence for a signaling bar code. The Journal of Biological Chemistry, 286, 11506–11508. https://doi.org/10.1074/jbc.M110.154526. ; Calebiro, D., & Godbole, A. (2018). Internalization of G‐protein‐coupled receptors: Implication in receptor function, physiology and diseases. Best Practice & Research. Clinical Endocrinology & Metabolism, 32, 83–91. https://doi.org/10.1016/j.beem.2018.01.004. ; Calebiro, D., Nikolaev, V. O., Gagliani, M. C., de Filippis, T., Dees, C., Tacchetti, C., Persani, L., & Lohse, M. J. (2009). Persistent cAMP‐signals triggered by internalized G‐protein‐coupled receptors. PLoS Biology, 7, e1000172. https://doi.org/10.1371/journal.pbio.1000172. ; Divorty, N., Jenkins, L., Ganguly, A., Butcher, A. J., Hudson, B. D., Schulz, S., Tobin, A. B., Nicklin, S. A., & Milligan, G. (2022). Agonist‐induced phosphorylation of orthologues of the orphan receptor GPR35 functions as an activation sensor. The Journal of Biological Chemistry, 298, 101655. https://doi.org/10.1016/j.jbc.2022.101655. ; Drube, J., Haider, R. S., Matthees, E. S. F., Reichel, M., Zeiner, J., Fritzwanker, S., Ziegler, C., Barz, S., Klement, L., Filor, J., Weitzel, V., Kliewer, A., Miess‐Tanneberg, E., Kostenis, E., Schulz, S., & Hoffmann, C. (2022). GPCR kinase knockout cells reveal the impact of individual GRKs on arrestin binding and GPCR regulation. Nature Communications, 13, 540. https://doi.org/10.1038/s41467-022-28152-8. ; Ferrandon, S., Feinstein, T. N., Castro, M., Wang, B., Bouley, R., Potts, J. T., Gardella, T. J., & Vilardaga, J. P. (2009). Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. Nature Chemical Biology, 5, 734–742. https://doi.org/10.1038/nchembio.206. ; Fredriksson, J., Holdfeldt, A., Mårtensson, J., Björkman, L., Møller, T. C., Müllers, E., Dahlgren, C., Sundqvist, M., & Forsman, H. (2022). GRK2 selectively attenuates the neutrophil NADPH‐oxidase response triggered by β‐arrestin recruiting GPR84 agonists. Biochimica et Biophysica Acta, Molecular Cell Research, 1869(7), 119262. https://doi.org/10.1016/j.bbamcr.2022.119262. ; Gagnon, L., Leduc, M., Thibodeau, J. F., Zhang, M. Z., Grouix, B., Sarra‐Bournet, F., Gagnon, W., Hince, K., Tremblay, M., Geerts, L., Kennedy, C. R. J., Hebert, R. L., Gutsol, A., Holterman, C. E., Kamto, E., Gervais, L., Ouboudinar, J., Richard, J., Felton, A., … Laurin, P. (2018). A newly discovered Antifibrotic pathway regulated by two fatty acid receptors: GPR40 and GPR84. The American Journal of Pathology, 188(5), 1132–1148. https://doi.org/10.1016/j.ajpath.2018.01.009. ; Gaidarov, I., Anthony, T., Gatlin, J., Chen, X., Mills, D., Solomon, M., Han, S., Semple, G., & Unett, D. J. (2018). Embelin and its derivatives unravel the signaling, proinflammatory and antiatherogenic properties of GPR84 receptor. Pharmacological Research, 131, 185–198. https://doi.org/10.1016/j.phrs.2018.02.021. ; Gurevich, V. V., & Gurevich, E. V. (2019). GPCR signaling regulation: The role of GRKs and Arrestins. Frontiers in Pharmacology, 10, 125. https://doi.org/10.3389/fphar.2019.00125. ; Haider, R. S., Matthees, E. S. F., Drube, J., Reichel, M., Zabel, U., Inoue, A., Chevigné, A., Krasel, C., Deupi, X., & Hoffmann, C. (2022). β‐arrestin1 and 2 exhibit distinct phosphorylation‐dependent conformations when coupling to the same GPCR in living cells. Nature Communications, 13, 5638. https://doi.org/10.1038/s41467-022-33307-8. ; Jenkins, L., Marsango, S., Mancini, S., Mahmud, Z. A., Morrison, A., McElroy, S. P., Bennett, K. A., Barnes, M., Tobin, A. B., Tikhonova, I. G., & Milligan, G. (2021). Discovery and characterization of novel antagonists of the Proinflammatory orphan receptor GPR84. ACS Pharmacology & Translational Science, 4, 1598–1613. https://doi.org/10.1021/acsptsci.1c00151. ; Kaspersen, M. H., Jenkins, L., Dunlop, J., Milligan, G., & Ulven, T. (2017). Succinct synthesis of saturated hydroxy fatty acids and in vitro evaluation of all hydroxylauric acids on FFA1, FFA4 and GPR84. Medchemcomm, 8, 1360–1365. https://doi.org/10.1039/c7md00130d. ; Kaya, A. I., Perry, N. A., Gurevich, V. V., & Iverson, T. M. (2020). Phosphorylation barcode‐dependent signal bias of the dopamine D1 receptor. Proceedings of the National Academy of Sciences of the United States of America, 117, 14139–14149. https://doi.org/10.1073/pnas.1918736117. ; Kenakin, T. (1995). Agonist‐receptor efficacy. II. Agonist trafficking of receptor signals. Trends in Pharmacological Sciences, 16, 232–238. https://doi.org/10.1016/S0165-6147(00)89032-X. ; Kenakin, T., & Christopoulos, A. (2013). Signalling bias in new drug discovery: Detection, quantification and therapeutic impact. Nature Reviews. Drug Discovery, 12(205), 205–216. https://doi.org/10.1038/nrd3954. ; Khalil, N., Manganas, H., Ryerson, C. J., Shapera, S., Cantin, A. M., Hernandez, P., Turcotte, E. E., Parker, J. M., Moran, J. E., Albert, G. R., Sawtell, R., Hagerimana, A., Laurin, P., Gagnon, L., Cesari, F., & Kolb, M. (2019). Phase 2 clinical trial of PBI‐4050 in patients with idiopathic pulmonary fibrosis. The European Respiratory Journal, 53(3), 1800663. https://doi.org/10.1183/13993003.00663-2018. ; Komolov, K. E., & Benovic, J. L. (2017). G protein‐coupled receptor kinases: Past, present and future. Cellular Signalling, 41, 17–24. https://doi.org/10.1016/j.cellsig.2017.07.004. ; Köse, M., Pillaiyar, T., Namasivayam, V., De Filippo, E., Sylvester, K., Ulven, T., von Kügelgen, I., & Müller, C. E. (2020). An agonist Radioligand for the Proinflammatory lipid‐activated G protein‐coupled receptor GPR84 providing structural insights. Journal of Medicinal Chemistry, 63(5), 2391–2410. https://doi.org/10.1021/acs.jmedchem.9b01339. ; Labeguere, F., Alvey, L., Newsome, G., Saniere, L., & Fletcher, S. (2014). Novel dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders. WO 2013/092791A1. ; Labéguère, F., Dupont, S., Alvey, L., Soulas, F., Newsome, G., Tirera, A., Quenehen, V., Mai, T. T. T., Deprez, P., Blanqué, R., Oste, L., Le Tallec, S., De Vos, S., Hagers, A., Vandevelde, A., Nelles, L., Vandervoort, N., Conrath, K., Christophe, T., … Gosmini, R. (2020). Discovery of 9‐Cyclopropylethynyl‐2‐((S)‐1‐[1,4]dioxan‐2‐ylmethoxy)‐6,7‐dihydropyrimido[6,1‐a]isoquinolin‐4‐one (GLPG1205), a unique GPR84 negative allosteric modulator undergoing evaluation in a phase II clinical trial. Journal of Medicinal Chemistry, 63, 13526–13545. https://doi.org/10.1021/acs.jmedchem.0c00272. ; Liu, Y., Zhang, Q., Chen, L. H., Yang, H., Lu, W., Xie, X., & Nan, F. J. (2016). Design and synthesis of 2‐Alkylpyrimidine‐4,6‐diol and 6‐Alkylpyridine‐2,4‐diol as potent GPR84 agonists. ACS Medicinal Chemistry Letters, 7(6), 579–583. https://doi.org/10.1021/acsmedchemlett.6b00025. ; Lucy, D., Purvis, G. S. D., Zeboudj, L., Chatzopoulou, M., Recio, C., Bataille, C. J. R., Wynne, G. M., Greaves, D. R., & Russell, A. J. (2019). A biased agonist at Immunometabolic receptor GPR84 causes distinct functional effects in macrophages. ACS Chemical Biology, 14(9), 2055–2064. https://doi.org/10.1021/acschembio.9b00533. ; Luscombe, V. B., Lucy, D., Bataille, C. J. R., Russell, A. J., & Greaves, D. R. (2020). 20 years an orphan: Is GPR84 a plausible medium‐chain fatty acid‐sensing receptor? DNA and Cell Biology, 39, 1926–1937. https://doi.org/10.1089/dna.2020.5846. ; Mancini, S. J., Mahmud, Z. A., Jenkins, L., Bolognini, D., Newman, R., Barnes, M., Edye, M. E., McMahon, S. B., Tobin, A. B., & Milligan, G. (2019). On‐target and off‐target effects of novel orthosteric and allosteric activators of GPR84. Scientific Reports, 9(1), 1861. https://doi.org/10.1038/s41598-019-38539-1. ; Marsango, S., Barki, N., Jenkins, L., Tobin, A. B., & Milligan, G. (2020). Therapeutic validation of an orphan G protein‐coupled receptor: The case of GPR84. British Journal of Pharmacology, 179, 3529–3541. https://doi.org/10.1111/bph.15248. ; Marsango, S., Ward, R. J., Jenkins, L., Butcher, A. J., Al Mahmud, Z., Dwomoh, L., Nagel, F., Schulz, S., Tikhonova, I. G., Tobin, A. B., & Milligan, G. (2022). Selective phosphorylation of threonine residues defines GPR84‐arrestin interactions of biased ligands. The Journal of Biological Chemistry, 298, 101932. https://doi.org/10.1016/j.jbc.2022.101932. ; Martínez‐Morales, J. C., Teresa Romero‐Ávila, M., Reyes‐Cruz, G., & García‐Sáinz, J. A. (2021). Roles of receptor phosphorylation and Rab proteins in G protein‐coupled receptor function and trafficking. Molecular Pharmacology, 101, 144–153. https://doi.org/10.1124/molpharm.121.000429. ; Matthees, E. S. F., Haider, R. S., Hoffmann, C., & Drube, J. (2021). Differential regulation of GPCRs‐are GRK expression levels the key? Frontiers in Cell and Development Biology, 9, 687489. https://doi.org/10.3389/fcell.2021.687489. ; Mikkelsen, R. B., Arora, T., Trošt, K., Dmytriyeva, O., Jensen, S. K., Meijnikman, A. S., Olofsson, L. E., Lappa, D., Aydin, Ö., Nielsen, J., Gerdes, V., Moritz, T., van de Laar, A., de Brauw, M., Nieuwdorp, M., Hjorth, S. A., Schwartz, T. W., & Bäckhed, F. (2022). Type 2 diabetes is associated with increased circulating levels of 3‐hydroxydecanoate activating GPR84 and neutrophil migration. iScience, 25, 105683. https://doi.org/10.1016/j.isci.2022.105683. ; Milligan, G., Marshall, F., Rees, S. (1996). G16 as a universal G protein adapter: Implications for agonist screening strategies. Trends in Pharmacological, 17(7), 235–237. ; Møller, T. C., Pedersen, M. F., van Senten, J. R., Seiersen, S. D., Mathiesen, J. M., Bouvier, M., & Bräuner‐Osborne, H. (2020). Dissecting the roles of GRK2 and GRK3 in μ‐opioid receptor internalization and β‐arrestin2 recruitment using CRISPR/Cas9‐edited HEK293 cells. Scientific Reports, 10, 17395. https://doi.org/10.1038/s41598-020-73674-0. ; Montgomery, M. K., Osborne, B., Brandon, A. E., O'Reilly, L., Fiveash, C. E., Brown, S. H. J., Wilkins, B. P., Samsudeen, A., Yu, J., Devanapalli, B., Hertzog, A., Tolun, A. A., Kavanagh, T., Cooper, A. A., Mitchell, T. W., Biden, T. J., Smith, N. J., Cooney, G. J., & Turner, N. (2019). Regulation of mitochondrial metabolism in murine skeletal muscle by the medium‐chain fatty acid receptor Gpr84. The FASEB Journal, 33(11), 12264–12276. https://doi.org/10.1096/fj.201900234R. ; Muredda, L., Kepczynska, M. A., Zaibi, M. S., Alomar, S. Y., & Trayhurn, P. (2018). IL‐1beta and TNFalpha inhibit GPR120 (FFAR4) and stimulate GPR84 (EX33) and GPR41 (FFAR3) fatty acid receptor expression in human adipocytes: Implications for the anti‐inflammatory action of n‐3 fatty acids. Archives of Physiology and Biochemistry, 124(2), 97–108. https://doi.org/10.1080/13813455.2017.1364774. ; Nagasaki, H., Kondo, T., Fuchigami, M., Hashimoto, H., Sugimura, Y., Ozaki, N., Arima, H., Ota, A., Oiso, Y., & Hamada, Y. (2012). Inflammatory changes in adipose tissue enhance expression of GPR84, a medium‐chain fatty acid receptor: TNFalpha enhances GPR84 expression in adipocytes. FEBS Letters, 586(4), 368–372. https://doi.org/10.1016/j.febslet.2012.01.001. ; Nikaido, Y., Koyama, Y., Yoshikawa, Y., Furuya, T., & Takeda, S. (2015). Mutation analysis and molecular modeling for the investigation of ligand‐binding modes of GPR84. Journal of Biochemistry, 157(5), 311–320. https://doi.org/10.1093/jb/mvu075. ; Ohue‐Kitano, R., Nonaka, H., Nishida, A., Masujima, Y., Takahashi, D., Ikeda, T., Uwamizu, A., Tanaka, M., Kohjima, M., Igarashi, M., Katoh, H., Tanaka, T., Inoue, A., Suganami, T., Hase, K., Ogawa, Y., Aoki, J., & Kimura, I. (2023). Medium‐chain fatty acids suppress lipotoxicity‐induced hepatic fibrosis via the immunomodulating receptor GPR84. JCI Insight, 8, e165469. https://doi.org/10.1172/jci.insight.165469. ; Parker, J., Sawtell, R., Gagnon, L., Hagerimania, A., Laurin, P., Kolb, M., & Moran, J. (2017). PBI‐4050 is safe and well tolerated and shows evidence of benefit in idiopathic pulmonary fibrosis. AJRCCM, 195, A7606. ; Peters, A., Rabe, P., Liebing, A. D., Krumbholz, P., Nordström, A., Jäger, E., Kraft, R., & Stäubert, C. (2022). Hydroxycarboxylic acid receptor 3 and GPR84 ‐ Two metabolite‐sensing G protein‐coupled receptors with opposing functions in innate immune cells. Pharmacological Research, 176, 106047. https://doi.org/10.1016/j.phrs.2021.106047. ; Pillaiyar, T., Köse, M., Sylvester, K., Weighardt, H., Thimm, D., Borges, G., Förster, I., von Kügelgen, I., & Müller, C. E. (2017). Diindolylmethane derivatives: Potent agonists of the Immunostimulatory orphan G protein‐coupled receptor GPR84. Journal of Medicinal Chemistry, 60(9), 3636–3655. https://doi.org/10.1021/acs.jmedchem.6b01593. ; Prihandoko, R., Alvarez‐Curto, E., Hudson, B. D., Butcher, A. J., Ulven, T., Miller, A. M., Tobin, A. B., & Milligan, G. (2016). Distinct phosphorylation clusters determine the signaling outcome of free fatty acid receptor 4/G protein‐coupled receptor 120. Molecular Pharmacology, 89, 505–520. https://doi.org/10.1124/mol.115.101949. ; Prihandoko, R., Bradley, S. J., Tobin, A. B., & Butcher, A. J. (2015). Determination of GPCR phosphorylation status: Establishing a phosphorylation barcode. Current Protocols in Pharmacology, 69, 2. https://doi.org/10.1002/0471141755.ph0213s69. ; Puengel, T., De Vos, S., Hundertmark, J., Kohlhepp, M., Guldiken, N., Pujuguet, P., Auberval, M., Marsais, F., Shoji, K. F., Saniere, L., Trautwein, C., Luedde, T., Strnad, P., Brys, R., Clement‐Lacroix, P., & Tacke, F. (2020). The medium‐chain fatty acid receptor GPR84 mediates myeloid cell infiltration promoting steatohepatitis and fibrosis. Journal of Clinical Medicine, 9(4), 1140. https://doi.org/10.3390/jcm9041140. ; Recio, C., Lucy, D., Purvis, G. S. D., Iveson, P., Zeboudj, L., Iqbal, A. J., Lin, D., O'Callaghan, C., Davison, L., Griesbach, E., Russell, A. J., Wynne, G. M., Dib, L., Monaco, C., & Greaves, D. R. (2018). Activation of the immune‐metabolic receptor GPR84 enhances inflammation and phagocytosis in macrophages. Frontiers in Immunology, 9, 1419. https://doi.org/10.3389/fimmu.2018.01419. ; Schulze, A. S., Kleinau, G., Krakowsky, R., Rochmann, D., Das, R., Worth, C. L., Krumbholz, P., Scheerer, P., & Stäubert, C. (2022). Evolutionary analyses reveal immune cell receptor GPR84 as a conserved receptor for bacteria‐derived molecules. iScience, 25, 105087. https://doi.org/10.1016/j.isci.2022.105087. ; Southern, C., Cook, J. M., Neetoo‐Isseljee, Z., Taylor, D. L., Kettleborough, C. A., Merritt, A., Bassoni, D. L., Raab, W. J., Quinn, E., Wehrman, T. S., Davenport, A. P., Brown, A. J., Green, A., Wigglesworth, M. J., & Rees, S. (2013). Screening β‐arrestin recruitment for the identification of natural ligands for orphan G‐protein‐coupled receptors. Journal of Biomolecular Screening, 18(5), 599–609. https://doi.org/10.1177/1087057113475480. ; Strambu, I. R., Seemayer, C. A., Fagard, L. M. A., Ford, P. A., Van der Aa, T. A. K., de Haas‐Amatsaleh, A. A., Modgill, V., Santermans, E., Sondag, E. N., Helmer, E. G., Maher, T. M., Costabel, U., & Cottin, V. (2022). GLPG1205 for idiopathic pulmonary fibrosis: A phase 2 randomised placebo‐controlled trial. The European Respiratory Journal, 3, 2201794. https://doi.org/10.1183/13993003.01794-2022. ; Suzuki, M., Takaishi, S., Nagasaki, M., Onozawa, Y., Iino, I., Maeda, H., Komai, T., & Oda, T. (2013). Medium‐chain fatty acid‐sensing receptor, GPR84, is a Proinflammatory receptor. The Journal of Biological Chemistry, 288(15), 10684–10691. https://doi.org/10.1074/jbc.M112.420042. ; Tobin, A. B., Butcher, A. J., & Kong, K. C. (2008). Location, location, location…Site‐specific GPCR phosphorylation offers a mechanism for cell‐type‐specific signalling. Trends in Pharmacological Sciences, 29, 413–420. https://doi.org/10.1016/j.tips.2008.05.006. ; Vermeire, S., Reinisch, W., Wasko‐Czopnik, D., Van Kaem, T., Desrivot, J., Vanhoutte, F., & Beetens, J. (2017). Efficacy and safety of GLPG1205, a GPR84 antagonist, in ulcerative colitis: Multi‐Centre proof‐of‐concept study. Journal of Crohn's and Colitis, 11(suppl_1), 390–391. https://doi.org/10.1093/ecco-jcc/jjx002.734. ; Wang, J., Wu, X., Simonavicius, N., Tian, H., & Ling, L. (2006). Medium‐chain fatty acids as ligands for orphan G protein‐coupled receptor GPR84. The Journal of Biological Chemistry, 281(45), 34457–34464. https://doi.org/10.1074/jbc.M608019200. ; Wei, L., Tokizane, K., Konishi, H., Yu, H. R., & Kiyama, H. (2017). Agonists for G‐protein‐coupled receptor 84 (GPR84) alter cellular morphology and motility but do not induce pro‐inflammatory responses in microglia. Journal of Neuroinflammation, 14(1), 198. https://doi.org/10.1186/s12974-017-0970-y. ; Yang, Z., Yang, F., Zhang, D., Liu, Z., Lin, A., Liu, C., Xiao, P., Yu, X., & Sun, J. P. (2017). Phosphorylation of G protein‐coupled receptors: From the barcode hypothesis to the flute model. Molecular Pharmacology, 92, 201–210. https://doi.org/10.1124/mol.116.107839. ; Zhang, Q., Chen, L. H., Yang, H., Fang, Y. C., Wang, S. W., Wang, M., Yuan, Q. T., Wu, W., Zhang, Y. M., Liu, Z. J., Nan, F. J., & Xie, X. (2022). GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation in macrophages. Acta Pharmacologica Sinica, 43, 2042–2054. https://doi.org/10.1038/s41401-021-00825-y. ; Zhang, Q., Yang, H., Li, J., & Xie, X. (2016). Discovery and characterization of a novel small‐molecule agonist for medium‐chain free fatty acid receptor G protein‐coupled receptor 84. The Journal of Pharmacology and Experimental Therapeutics, 357(2), 337–344. https://doi.org/10.1124/jpet.116.232033.
- Grant Information: BB/T000562/1 Biotechnology and Biosciences Research Council
- Contributed Indexing: Keywords: GPCR phosphorylation; GPCR regulation; GPR84; GRKs
- Substance Nomenclature: 0 (Arrestin) ; 0 (GPR84 protein, human) ; 0 (Receptors, G-Protein-Coupled)
- Entry Date(s): Date Created: 20230421 Date Completed: 20240418 Latest Revision: 20240422
- Update Code: 20240423
|
